Why Cannabis Rescheduling Is Here to Stay

Yesterday marked one of the most consequential moments in modern American drug policy. With the stroke of a pen, Donald Trump signed an executive order directing the movement of cannabis from Schedule I to Schedule III under the Controlled Substances Act, effectively ending the federal government’s long-held position that cannabis has no accepted medical use.

For those of us who have followed cannabis policy closely, the moment felt both historic and inevitable. Historic because it formally dismantles one of the core pillars of prohibition. Inevitable because public opinion, medical research, economic pressure, and global precedent have been building toward this outcome for years.

Almost immediately, familiar questions surfaced across newsrooms and social media feeds: Can this be undone? Will Congress step in? Is this symbolic or permanent?

In my opinion, this executive order is not only unlikely to be reversed, but it has fundamentally reshaped the political landscape around cannabis in a way neither party can afford to ignore or attempt to reverse.

What an Executive Order Really Means and What It Takes to Undo One

An executive order is not a press release or a campaign promise. It is a binding directive that governs how federal agencies interpret and enforce the law. In this case, the order instructs agencies such as the Department of Justice and the Drug Enforcement Administration to recognize cannabis as a Schedule III substance rather than Schedule I.

That distinction is critical.

Schedule I substances are legally defined as having no accepted medical use and a high potential for abuse. Schedule III substances are explicitly recognized as having medical value. This shift immediately alters the federal government’s posture toward cannabis, affecting research approvals, tax treatment, banking access, insurance considerations, and the overall legitimacy of state-legal markets.

Just as importantly, it sends a clear signal to courts, regulators, investors, and international partners that the United States has formally moved away from the scientific fiction underpinning prohibition.

To overturn an executive order like this, one of three things must happen:

• A future president would need to issue a new executive order reversing it.
• Congress would need to pass legislation explicitly overriding it.
• Or the courts would need to find it unlawful.

While each of these paths is technically possible, politically, they are extraordinarily unlikely.

Why Cannabis Rescheduling Is Politically Untouchable in Congress

Public support for cannabis reform now sits at approximately 82 percent nationwide, cutting across party lines, age groups, and regions. That level of consensus is rare in modern American politics.

For Democrats, this creates a delicate reality. President Joe Biden publicly acknowledged the need for cannabis reform and rescheduling during his administration. The rhetoric was there. The acknowledgment was there. However, the promise and follow-through never fully materialized.

Cannabis reform became another example of a familiar frustration: bold language without decisive action.

If Democratic lawmakers were now to attempt to overturn the most meaningful federal cannabis reform ever enacted, especially after years of campaigning on the issue on state and federal levels, it would severely damage trust with a voter base that is already skeptical. At a time when Democrats are working to regain lost seats and re-energize turnout, undermining cannabis reform would be politically self-destructive.

Republicans see this moment differently.

Within conservative and business-oriented circles, cannabis rescheduling is increasingly viewed as a win precisely because it represents action, not talk. Many Republicans now argue that while Democrats mentioned reform, it was Republicans who finally moved the policy forward in a concrete way. That narrative is already gaining traction, and it matters.

Undoing the executive order would mean surrendering a rare political advantage, one that reframes the party as pragmatic, economically savvy, and responsive to public opinion.

In a deeply polarized America, cannabis rescheduling has become one of the few issues where opposing reform carries more political risk than embracing it. This is why, despite partisan tension, cannabis rescheduling is one of the safest reforms on the board. It benefits both sides in different ways and punishes anyone who attempts to reverse course.

Why I Always Knew President Trump Would Be the One to Reschedule Cannabis

I’ve said it for years, sometimes quietly and sometimes out loud: if any president was going to make this move, it would be President Trump.

Not because of ideology, but because of economics.

At the end of the day, President Trump is a businessman. He understands scale, timing, leverage, and opportunity cost. He recognizes when an industry has outgrown outdated regulation and when ignoring that reality becomes economically irresponsible.

The U.S. cannabis industry already generates tens of billions of dollars annually despite federal prohibition. It employs hundreds of thousands of Americans across agriculture, manufacturing, logistics, technology, and retail. Yet it has been forced to operate without standard banking access, fair tax treatment, or federal legitimacy.

That contradiction is bad business.

Trump has a documented history of supporting cannabis-related measures tied to states’ rights, medical research, and criminal justice reform. This executive order did not appear in a vacuum, but it fits a broader pattern of pragmatic, results-driven decision-making.

At a moment when the U.S. economy is under pressure and global competition is fierce, cannabis is not a fringe issue. It is an economic opportunity hiding in plain sight, and President Trump could no longer ignore it.

The Economic Impact of Cannabis Rescheduling

Legal cannabis represents one of the largest untapped economic opportunities in the United States.

Rescheduling alone removes the punitive tax burden imposed by IRS Code 280E, allowing cannabis businesses to operate like any other legal industry. That means:

• Increased profitability
• Higher wages
• Expanded hiring
• Greater tax compliance
• More investment capital flowing into local economies

And this is just the beginning.

We do not have to guess what legalization could do for America; we can look north.

In Canada, federal legalization has generated billions in tax revenue, created tens of thousands of jobs, boosted agricultural innovation, and normalized cannabis as a legitimate consumer product. The economic impact is undeniable.

Now imagine that scale applied to the United States. From rural farming communities to urban manufacturing hubs, cannabis legalization has the potential to:

• Revitalize struggling agricultural regions
• Create unionized manufacturing and distribution jobs
• Fund infrastructure, education, and healthcare through tax revenue
• Reduce enforcement and incarceration costs
• Expand medical research and pharmaceutical development

At a time when the U.S. economy is under strain, cannabis is not a risk, but a relief valve that will directly trickle down to Americans who have been struggling with inflation and soaring costs for many years. As Americans are demanding real economic solutions, cannabis offers one that already works.

Cannabis Rescheduling as a Catalyst for Criminal Justice Reform

Rescheduling does not just reshape markets; it reshapes morality.

Once the federal government acknowledges cannabis has medical value, the justification for decades of arrests, incarceration, and lifelong criminal records collapses. Courts, lawmakers, and advocacy organizations will face increasing pressure to address expungement, resentencing, and reinvestment in communities disproportionately harmed by prohibition.

With the stroke of a pen, yesterday’s executive order began the catalyst for the moral and legal foundation of prohibition to crumble.

Rescheduling Is Not the End. It’s the Beginning.

Let’s be clear: moving cannabis to Schedule III does not equal legalization. But it does something just as important, it legitimizes the plant at the federal level.

That legitimacy accelerates everything from broader medical research and stronger arguments for federal legalization, to increased pressure for criminal justice reform. This is how real reform happens, not overnight, but through irreversible steps forward.

This executive order did more than change a classification. It changed the political conversation.

It reframed cannabis as an economic asset instead of a political liability, exposed the difference between rhetoric and action, and it demonstrated that meaningful reform is possible, even in a divided America.

Reversing this decision would require defying public opinion, economic logic, and global momentum. No party benefits from that, no administration gains credibility by undoing it, and no serious leader wants to be remembered as the one who tried to put the genie back in the bottle.

This historical shift will accelerate the path toward full federal legalization, meaningful criminal justice reform, and a cannabis industry rooted in science, fairness, and opportunity.

Today, for the first time in a long time, the momentum feels undeniable.